28. Liao H, Wu J, Kuhn E, Chin W, Chang B, et al. (2004) Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum 50: 3792– 3803. 29. Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, et al. (1987) Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330: 80–82. 30. Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, et al. (2006) The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen- activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 8: R69. 31. van Lent PL, Grevers L, Blom AB, Sloetjes A, Mort JS, et al. (2008) Myeloid- related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis. Ann Rheum Dis 67: 1750–1758. 32. Rampersad RR, Esserman D, McGinnis MW, Lee DM, Patel DD, et al. (2009) S100A9 is not essential for disease expression in an acute (K/BxN) or chronic (CIA) model of inflammatory arthritis. Scand J Rheumatol 38: 445–449. 33. Lim SY, Raftery MJ, Geczy CL (2011) Oxidative modifications of DAMPs suppress inflammation: the case for S100A8 and S100A9. Antioxid Redox Signal 15: 2235–2248. 34. Kido J, Kido R, Suryono, Kataoka M, Fagerhol MK, et al. (2004) Induction of calprotectin release by Porphyromonas gingivalis lipopolysaccharide in human neutrophils. Oral Microbiol Immunol 19: 182–187. 35. Ryckman C, Gilbert C, de Medicis R, Lussier A, Vandal K, et al. (2004) Monosodium urate monohydrate crystals induce the release of the proin- flammatory protein S100A8/A9 from neutrophils. J Leukoc Biol 76: 433–440. 36. Hogg N, Allen C, Edgeworth J (1989) Monoclonal antibody 5.5 reacts with p8,14, a myeloid molecule associated with some vascular endothelium. Eur J Immunol 19: 1053–1061. 37. Robinson MJ, Tessier P, Poulsom R, Hogg N (2002) The S100 family heterodimer, MRP-8/14, binds with high affinity to heparin and heparan sulfate glycosaminoglycans on endothelial cells. J Biol Chem 277: 3658–3665. 38. Yu T, Wu X, Gupta KB, Kucik DF (2010) Affinity, lateral mobility, and clustering contribute independently to beta 2-integrin-mediated adhesion. Am J Physiol Cell Physiol 299: C399–410. 39. Leirisalo-Repo M (1994) The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol Toxicol 75 Suppl 2: 1–3. Role of S100A9 in Arthritis 40. Klugewitz K, Ley K, Schuppan D, Nuck R, Gaehtgens P, et al. (1997) Activation of the beta2 integrin Mac-1 (CD11b/CD18) by an endogenous lipid mediator of human neutrophils and HL-60 cells. J Cell Sci 110 (Pt 8): 985–990. 41. Nishimoto N, Ito A, Ono M, Tagoh H, Matsumoto T, et al. (2000) IL-6 inhibits the proliferation of fibroblastic synovial cells from rheumatoid arthritis patients in the presence of soluble IL-6 receptor. Int Immunol 12: 187–193. 42. Yoshitake F, Itoh S, Narita H, Ishihara K, Ebisu S (2008) Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-kappaB signaling pathways. J Biol Chem 283: 11535–11540. 43. Grevers LC, de Vries TJ, Vogl T, Abdollahi-Roodsaz S, Sloetjes AW, et al. (2011) S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: Implications for bone destruction in murine antigen- induced arthritis. Arthritis Rheum 63: 1365–1375. 44. Schelbergen RFPvL, Peter L.; Blom, Arjen B.; Sloetjes, Annet; Vogl, Thomas; Roth, Johannes; Van Den Berg Wim B (2010) Alarmins S100A8 and S100A9 Skew Human Chondrocytes towards a Cartilage Breakdown Phenotype. Annual Scientific Meeting Atlanta, geprgia: Abstracts of the American College of Rheumatology/Association of Rheumatology Health Professionals. 45. Koenders MI, Marijnissen RJ, Devesa I, Lubberts E, Joosten LA, et al. (2011) TNF/IL-17 interplay induces S100A8, IL-1beta, and MMPs, and drives irreversible cartilage destruction In Vivo: Rationale for combination treatment during arthritis. Arthritis Rheum. 46. Simard JC, Simon MM, Tessier PA, Girard D (2011) Damage-associated molecular pattern S100A9 increases bactericidal activity of human neutrophils by enhancing phagocytosis. J Immunol 186: 3622–3631. 47. Nemeth J, Stein I, Haag D, Riehl A, Longerich T, et al. (2009) S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. Hepatology 50: 1251– 1262. 48. Salama I, Malone PS, Mihaimeed F, Jones JL (2008) A review of the S100 proteins in cancer. Eur J Surg Oncol 34: 357–364. 49. Shibata F, Ito A, Ohkuma Y, Mitsui K (2005) Mitogenic activity of S100A9 (MRP-14). Biol Pharm Bull 28: 2312–2314. 50. Konttinen YT, Li TF, Hukkanen M, Ma J, Xu JW, et al. (2000) Fibroblast biology. Signals targeting the synovial fibroblast in arthritis. Arthritis Res 2: 348– 355. 51. Loser K, Vogl T, Voskort M, Lueken A, Kupas V, et al. (2010) The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med 16: 713–717. PLOS ONE | www.plosone.org 12 September 2012 | Volume 7 | Issue 9 | e45478